Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInventory AverageInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Unicycive Therapeutics (UNCY) Return on Equity (2021 - 2026)

Unicycive Therapeutics filings provide 3 years of Return on Equity readings, the most recent being 0.03% for Q4 2024.

  • On a quarterly basis, Return on Equity fell 105.0% to 0.03% in Q4 2024 year-over-year; TTM through Dec 2024 was 0.03%, a 105.0% decrease, with the full-year FY2024 number at 0.17%, down 27.0% from a year prior.
  • Return on Equity hit 0.03% in Q4 2024 for Unicycive Therapeutics, up from 0.01% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 1.08% in Q4 2023 to a low of 0.09% in Q4 2022.
  • Median Return on Equity over the past 3 years was 0.02% (2024), compared with a mean of 0.11%.
  • Biggest five-year swings in Return on Equity: surged 117bps in 2023 and later plummeted -105bps in 2024.
  • Unicycive Therapeutics' Return on Equity stood at 0.09% in 2022, then skyrocketed by 1343bps to 1.08% in 2023, then crashed by -97bps to 0.03% in 2024.
  • The last three reported values for Return on Equity were 0.03% (Q4 2024), 0.01% (Q3 2024), and 0.01% (Q2 2024) per Business Quant data.